IONS
Ionis Pharmaceuticals IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$12.21B
P/E Ratio
—
EPS
$-2.38
Beta
0.40
52W High
$86.74
52W Low
$25.74
50-Day MA
$78.43
200-Day MA
$66.47
Dividend Yield
—
Profit Margin
-40.40%
Forward P/E
96.15
PEG Ratio
27.33
About Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California.
Fundamentals
| Revenue (TTM) | $943.71M |
| Gross Profit (TTM) | $12.18M |
| EBITDA | $-369.24M |
| Operating Margin | -105.50% |
| Return on Equity | -70.80% |
| Return on Assets | -7.31% |
| Revenue/Share (TTM) | $5.90 |
| Book Value | $3.00 |
| Price-to-Book | 25.26 |
| Price-to-Sales (TTM) | 12.93 |
| EV/Revenue | 12.44 |
| EV/EBITDA | 135.77 |
| Quarterly Earnings Growth (YoY) | -43.70% |
| Quarterly Revenue Growth (YoY) | -10.30% |
| Shares Outstanding | $165.19M |
| Float | $163.91M |
| % Insiders | 0.71% |
| % Institutions | 105.85% |
Analyst Ratings
Consensus ($96.81 target)
6
Strong Buy10
Buy6
HoldData last updated: 4/8/2026